icone plus
Contact Abonnez-vous aux actualités
Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
eNq1mF1v2jAUhu/5FVHuSQIrH5sC1cbohtSqjBZt2k1lkgOYpXZ6bAPdr59D6EYnR20NvoztvOfE5/Xjo8Tn2/vMWwMKylnPbwSR7wFLeErZoudPby/qXf+8X4tXZE0OlnWCKGg0fS/JiBA9v5gNZkCYCH5cXX4G/T6g3695MZ+tIJHP1ilJs+ArEcsrkhdrvHjNaerdg1zytOfnSu5GvVhI1Fn0Nxx/iZwkEIf7kcPZ1d3Z4XgcFmKvUFUC8JKwhVEUmJVmohCByQGRsOD4aJSeJ3fNbqcdRV2rEFRMQHCFCYyJXI6Rr2kKqTkSyQRYBZlv0hvAdQayCGIUD1fJvbASJyuyncDDyJz0Rz07kFtZj+qNTqvZbkRRq9OJIqtQeLBVZvPojwh1Qd63W912MwQWSkh0BZE+WFZnzFGSzFFdqBg8d5ijOAgPL9Y/pSLPyGOwErntVhEkehpQc8DdhxRfcIuaTJnes//0mcqy8I1ZT/fccJRxgaUBV9qCZnxcTGw3YsCZhG11Re2IJ7d7L1IQp5P9zZmZ9mM1y2hiCzWNHQVCTiejaqadFgefiIApuuPBd8pSvhGn58xhXR1ln+9QaRTNMW3oMnTbjVbL+hj91CaquGWGCnkOoSYQFceAZcTm/FikaF+apZ5ceUJD7poenpAMKtqeuiVftBOfujRnXnd3jsoJo+iX4a2tQb4pwMeb3aNRmqa9v6W1g68Loms7Vib+dnOXZ/wVDfFZ953dJig0I2QpZS4+hOGSiLogeqOCOToA/MGt6q4Zd3J1l61MCUlHqc/K2+/19bE9ai9d7Mc2q/v3902xMYZEBUfUoaSyM3aOhqfH8b9O1Vna42f4cBdm11USSTlz1euomVHxuAtA15VdoIbD9XxOK/6PVPoyDst/M/1aHBb/Zfq1PzRy6HI=
QvMrxPLq3d3DDgfc
Listen
